Safety Considerations for Diagnostic Naproxen Use

Cardiovascular Risks

• In patients with known cardiovascular disease, the use of naproxen for diagnostic purposes should be approached with extreme caution because non‑steroidal anti‑inflammatory drugs increase the risk of cardiac ischemic events. Citation: Circulation (2007) 1.

Gastrointestinal Protection

• For individuals aged ≥ 60 years or those with a history of peptic ulcer disease, co‑administration of a proton‑pump inhibitor is recommended when using naproxen diagnostically to mitigate gastrointestinal adverse effects. Citation: Praxis Medical Insights (2025) 3.

Renal Monitoring

• Monitoring of blood urea nitrogen and serum creatinine is advised during naproxen diagnostic trials, especially in elderly patients or those with pre‑existing renal impairment, to detect potential renal function deterioration. Citation: Praxis Medical Insights (2026) 4.